TMTatsuro Miyoshi

Tatsuro Miyoshi

*This is an algorithmically generated author record based on publicly available information.

Tatsuro Miyoshi has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Dual-mechanism vitamin C delivery by polyethylene glycol-23 glyceryl distearate-based niosomes via SVCT2 induction and enhanced transdermal penetration

    by Tatsuro Miyoshi, Brian C. Keller, Sui Nakagawa, Takashi Ashino, Asuka Kaizaki-Mitsumoto, Satoshi Numazawa

    Polyethylene glycol-23 glyceryl distearate (GDS-23)-a noisome-forming diacylglycerol-polyethylene glycol-based nonionic surfactant-functions as a nanocarrier for drug delivery systems (DDS) and an enhancer of endogenous antioxidant capacity through nuclear factor erythroid 2-related factor 2 (Nrf2) activation. Here, we evaluated the potential of GDS-23 as a multifunctional DDS carrier by investigating the combined contribution of (i) improved transdermal delivery mediated by niosomal DDS and (ii) increased cellular uptake associated with induction of antioxidant-related transporters, using protection against oxidative-stress-induced tissue damage as a functional readout. We determined whether GDS-23 modulates the expression of the antioxidant-related transporters xCT and SVCTs through Nrf2 activation. In normal human epidermal keratinocytes, GDS-23 treatment significantly upregulated the mRNA expression of xCT (SLC7A11; cystine/glutamate antiporter) and sodium-dependent vitamin C transporter 2 (SVCT2). The induction was diminished by an Nrf2 activation inhibitor (K67), indicating involvement of the Nrf2 pathway. Furthermore, evaluation using a three-dimensional reconstructed epidermis model with calcein sodium as a fluorescent tracer revealed that GDS-23-based niosomes facilitated skin permeation. When L-ascorbic acid or cysteine was encapsulated within these niosomes, hydroquinone-induced oxidative tissue damage was attenuated, with the L-ascorbic acid-loaded niosomes exhibiting the most prominent protective effect. Overall, this study shows that Nrf2 activation contributes to SVCT2 induction and that GDS-23 is a multifunctional DDS nanocarrier that enhances skin permeation and may promote intracellular uptake by upregulating antioxidant-related transporters. These findings highlight the therapeutic potential of combining functional nanocarriers with entrapped bioactive molecules, offering a promising strategy for efficient treatment of skin disorders and antioxidant-based interventions.

  • Open Access

    PEG‐23 glyceryl distearate, a multifunctional skin‐supporting material, upregulates the expression of factors associated with epidermal barrier and hydration

    by Tatsuro Miyoshi, Brian C. Keller, Sui Nakagawa, Takashi Ashino, Satoshi Numazawa

    Objective: As the outermost organ of the human body, the skin plays a critical role in protecting against external agents and oxidative stress, as well as in preventing excessive water loss. Among its layers, the stratum corneum of the epidermis is central to both barrier function and moisture retention, with its structural integrity significantly influencing skin health and appearance. Polyethylene glycol‐23 glyceryl distearate (GDS‐23) can form niosomes, liposome‐like structures with multiple layers and serve as a carrier in drug delivery systems (DDS). We previously reported that GDS‐23 exerts multiple biological effects, suppressing inflammation and enhancing the endogenous antioxidant system via Nrf2 activation through phosphorylation of the autophagy adaptor protein p62. In this study, we investigated the effects of GDS‐23 on epidermal barrier function and moisture retention using normal human epidermal keratinocytes (NHEKs) and a three‐dimensional (3D) epidermal model, mimicking human skin structure. Methods: NHEKs and the 3D epidermal model were treated with GDS‐23. Gene expression in NHEKs was analysed using real‐time polymerase chain reaction, while the levels of epidermal barrier‐ and moisture retention‐related factors in the 3D model were evaluated using immunofluorescence staining. Results: Treatment with GDS‐23 upregulated the mRNA expression of genes involved in stratum cornea formation (filaggrin and loricrin), moisture retention (aquaporin 3 and hyaluronan synthase 3) and intercellular lipid synthesis (ceramide synthase, sulfotransferase 2B1 and peroxisome proliferator‐activated receptor α) in NHEKs. Additionally, treatment with K67, which inhibits p62 phosphorylation and thereby suppresses Nrf2 activation via a non‐canonical mechanism, suppressed the GDS‐23‐induced expression of filaggrin, loricrin, ceramide synthase, sulfotransferase 2B1 and aquaporin 3. In the 3D epidermal model, GDS‐23 treatment upregulated the expression of Nrf2, downstream antioxidant factors and proteins involved in stratum corneum formation and moisture regulation. Mechanistically, GDS‐23 enhanced endogenous antioxidant function and modulated the expression of molecular markers associated with epidermal barrier and moisture retention, thereby potentially contributing to skin homeostasis. Conclusion: As GDS‐23 contributes to the maintenance of skin homeostasis, it is expected to have future applications in the cosmetic field and in the treatment of skin disorders. Overall, GDS‐23 holds promise as a “multifunctional DDS material” that promotes skin health.


  • Open Access

    Noncanonical mechanism of Nrf2 activation by diacylglycerol polyethylene glycol adducts in normal human epidermal keratinocytes

    by Tatsuro Miyoshi, Brian C. Keller, Takashi Ashino, Satoshi Numazawa

    Polyethylene glycol-23 glyceryl distearate (GDS-23), a diacylglycerol polyethylene glycol adduct, forms niosomes with a liposome-like structure and functions as an active ingredient in drug delivery systems. In addition, it upregulates antioxidant proteins such as heme oxygenase 1 and NAD(P)H-quinone dehydrogenase 1 in cells. However, the activation of nuclear factor E2-related factor-2 (Nrf2), which plays a role in inducing the expression of antioxidant proteins, and its protective effects induced by GDS-23 treatment against oxidative stress have not been elucidated. This study aimed at verifying the activation of Nrf2 by GDS-23 and clarifying its underlying mechanisms, and investigated whether GDS-23 protects against hydroquinone-induced cytotoxicity. Normal human epidermal keratinocytes were treated with GDS-23. Real-time reverse transcription-polymerase chain reaction, western blotting, and immunostaining were used to investigate the mechanism of Nrf2 activation, and neutral red assay was performed to evaluate cytotoxicity. GDS-23-treated cells showed an increase in antioxidant protein levels and stabilization of Nrf2 in the nucleus. During Nrf2 activation, p62, an autophagy-related adaptor protein, was phosphorylated at Ser349. Inhibition of the interaction between the phosphorylated p62 and Kelch-like ECH-associated protein 1 significantly suppressed the GDS-23-mediated induction of antioxidant protein expression. In addition, hydroquinone-induced cell toxicity was significantly attenuated by GDS-23. GDS-23 induced the intracellular antioxidant system by activating Nrf2 in a p62 phosphorylation-dependent manner without generating oxidative stress in the cells. GDS-23 may be applied as a multifunctional material for drug delivery system that enhances internal antioxidant systems.